AZN.L : Summary for ASTRAZENECA PLC ORD SHS $0.25 - Yahoo Finance

U.S. Markets open in 7 hrs 50 mins

AstraZeneca PLC (AZN.L)


LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
4,530.50-45.00 (-0.98%)
At close: 5:04PM GMT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close4,575.50
Open4,543.50
Bid4,500.00 x 6100
Ask4,660.00 x 13000
Day's Range4,529.00 - 4,688.01
52 Week Range3,680.00 - 5,505.00
Volume2,601,103
Avg. Volume2,848,063
Market Cap57.32B
Beta0.46
PE Ratio (TTM)23.25
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend DateN/A
1y Target EstN/A
  • FDA Track Record Bodes Well For Merck Keytruda Plus Chemo: Leerink
    Investor's Business Daily9 hours ago

    FDA Track Record Bodes Well For Merck Keytruda Plus Chemo: Leerink

    The FDA's track record for oncology "hits" bodes well for Merck's Keytruda plus chemo combo, Leerink says.

  • Financial Times17 hours ago

    [$$] AstraZeneca expands trials for key cancer drug

    Anglo-Swedish drugmaker AstraZeneca is expanding its widely watched trials for durvalumab, a potential breakthrough treatment for several forms of cancer. The drug is among a group of therapies designed ...

  • Barrons.com7 days ago

    2 Stocks For a Trump-ed Up Pharma Market

    As my colleague Johanna Bennett noted, comments made by President-elect Donald Trump today about the high prices of drugs, as well as the fact that so many are manufactured outside the U.S. has helped sink biotech and pharmaceutical stocks alike.